Squarepoint Ops LLC Gilead Sciences, Inc. Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 33,520 shares of GILD stock, worth $3.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,520

Previous 1,874,436 98.21%

Holding current value

$3.1 Million

Previous $129 Million 97.82%

% of portfolio

0.0%

Previous 0.22%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $123 Million - $155 Million	-1,840,916 Reduced 98.21%	33,520 $2.81 Million
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $70.7 Million - $81.6 Million	1,119,829 Added 148.4%	1,874,436 $129 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $47.5 Million - $58 Million	664,099 Added 733.75%	754,607 $55.3 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $3.09 Million - $3.5 Million	42,151 Added 87.17%	90,508 $7.33 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $3.68 Million - $4.19 Million	48,357 New	48,357 $3.73 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $10.1 Million - $14.4 Million	161,457 Added 1028.13%	177,161 $15.2 Million
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $12.6 Million - $14.4 Million	-212,100 Reduced 93.11%	15,704 $969,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $23.3 Million - $26.3 Million	-403,976 Reduced 63.94%	227,804 $14.1 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $20.3 Million - $25.5 Million	351,325 Added 125.27%	631,780 $37.6 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $16.6 Million - $18.9 Million	255,998 Added 1046.73%	280,455 $20.4 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $5.17 Million - $5.57 Million	-76,315 Reduced 75.73%	24,457 $1.71 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $1.4 Million - $1.53 Million	22,062 Added 28.03%	100,772 $6.94 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $47.8 Million - $54.5 Million	-796,719 Reduced 91.01%	78,710 $5.09 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $23.6 Million - $26.9 Million	417,299 Added 91.09%	875,429 $51 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $27.4 Million - $34.5 Million	441,687 Added 2686.17%	458,130 $28.9 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $1.19 Million - $1.38 Million	16,443 New	16,443 $1.27 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $42.8 Million - $54.8 Million	-683,459 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $17 Million - $18.7 Million	-276,315 Reduced 28.79%	683,459 $44.4 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $37.2 Million - $41 Million	594,316 Added 162.62%	959,774 $60.8 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $15.3 Million - $17.2 Million	-247,995 Reduced 40.43%	365,458 $24.7 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $8.3 Million - $9.3 Million	132,729 Added 27.61%	613,453 $39.9 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $29.1 Million - $38 Million	480,724 New	480,724 $30.1 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.82 Million - $2.02 Million	-25,600 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $2.82 Million - $3.29 Million	-43,497 Reduced 62.95%	25,600 $1.81 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $2.44 Million - $2.97 Million	-33,494 Reduced 32.65%	69,097 $5.21 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $7.3 Million - $8.57 Million	102,591	102,591 $7.35 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account

Squarepoint Ops LLC Gilead Sciences, Inc. Transaction History